Cargando…

Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?

Pseudomonas aeruginosa is an important Gram‐negative pathogen with intrinsic resistance to many clinically used antibiotics. It is particularly troublesome in nosocomial infections, immunocompromised patients, and individuals with cystic fibrosis. Antimicrobial resistance (AMR) is a huge threat to g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyon, Rhiannon, Jones, Rebekah A., Shropshire, Holly, Aberdeen, Isabel, Scanlan, David J., Millard, Andrew, Chen, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804370/
https://www.ncbi.nlm.nih.gov/pubmed/35837865
http://dx.doi.org/10.1111/1462-2920.16136
_version_ 1784862092591890432
author Lyon, Rhiannon
Jones, Rebekah A.
Shropshire, Holly
Aberdeen, Isabel
Scanlan, David J.
Millard, Andrew
Chen, Yin
author_facet Lyon, Rhiannon
Jones, Rebekah A.
Shropshire, Holly
Aberdeen, Isabel
Scanlan, David J.
Millard, Andrew
Chen, Yin
author_sort Lyon, Rhiannon
collection PubMed
description Pseudomonas aeruginosa is an important Gram‐negative pathogen with intrinsic resistance to many clinically used antibiotics. It is particularly troublesome in nosocomial infections, immunocompromised patients, and individuals with cystic fibrosis. Antimicrobial resistance (AMR) is a huge threat to global health, with a predicted 10 million people dying from resistant infections by 2050. A promising therapy for combatting AMR infections is phage therapy. However, more research is required to investigate mechanisms that may influence the efficacy of phage therapy. An important overlooked aspect is the impact of membrane lipid remodelling on phage binding ability. P. aeruginosa undergoes changes in membrane lipids when it encounters phosphorus stress, an environmental perturbation that is likely to occur during infection. Lipid changes include the substitution of glycerophospholipids with surrogate glycolipids and the over‐production of ornithine‐containing aminolipids. Given that membrane lipids are known to influence the structure and function of membrane proteins, we propose that changes in the composition of membrane lipids during infection may alter phage binding and subsequent phage infection dynamics. Consideration of such effects needs to be urgently prioritised in order to develop the most effective phage therapy strategies for P. aeruginosa infections.
format Online
Article
Text
id pubmed-9804370
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98043702023-01-03 Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy? Lyon, Rhiannon Jones, Rebekah A. Shropshire, Holly Aberdeen, Isabel Scanlan, David J. Millard, Andrew Chen, Yin Environ Microbiol Minireviews Pseudomonas aeruginosa is an important Gram‐negative pathogen with intrinsic resistance to many clinically used antibiotics. It is particularly troublesome in nosocomial infections, immunocompromised patients, and individuals with cystic fibrosis. Antimicrobial resistance (AMR) is a huge threat to global health, with a predicted 10 million people dying from resistant infections by 2050. A promising therapy for combatting AMR infections is phage therapy. However, more research is required to investigate mechanisms that may influence the efficacy of phage therapy. An important overlooked aspect is the impact of membrane lipid remodelling on phage binding ability. P. aeruginosa undergoes changes in membrane lipids when it encounters phosphorus stress, an environmental perturbation that is likely to occur during infection. Lipid changes include the substitution of glycerophospholipids with surrogate glycolipids and the over‐production of ornithine‐containing aminolipids. Given that membrane lipids are known to influence the structure and function of membrane proteins, we propose that changes in the composition of membrane lipids during infection may alter phage binding and subsequent phage infection dynamics. Consideration of such effects needs to be urgently prioritised in order to develop the most effective phage therapy strategies for P. aeruginosa infections. John Wiley & Sons, Inc. 2022-08-14 2022-10 /pmc/articles/PMC9804370/ /pubmed/35837865 http://dx.doi.org/10.1111/1462-2920.16136 Text en © 2022 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Minireviews
Lyon, Rhiannon
Jones, Rebekah A.
Shropshire, Holly
Aberdeen, Isabel
Scanlan, David J.
Millard, Andrew
Chen, Yin
Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
title Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
title_full Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
title_fullStr Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
title_full_unstemmed Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
title_short Membrane lipid renovation in Pseudomonas aeruginosa ‐ implications for phage therapy?
title_sort membrane lipid renovation in pseudomonas aeruginosa ‐ implications for phage therapy?
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804370/
https://www.ncbi.nlm.nih.gov/pubmed/35837865
http://dx.doi.org/10.1111/1462-2920.16136
work_keys_str_mv AT lyonrhiannon membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy
AT jonesrebekaha membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy
AT shropshireholly membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy
AT aberdeenisabel membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy
AT scanlandavidj membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy
AT millardandrew membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy
AT chenyin membranelipidrenovationinpseudomonasaeruginosaimplicationsforphagetherapy